Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psychedelic Effects of Psychoactive Substances in Healthy Volunteers
NCT06772753Phase 1Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Feb 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ketamine, dextromethorphan, DMT, midomafetamine and dronabinol (3 arms), sponsored by Johns Hopkins University. Primary endpoint: Mystical Experience Questionnaire at Week 7. Started Feb 2025; status: recruiting.
02
Drugs
ketaminedextromethorphanDMTmidomafetaminedronabinol
Beyond the preview
Go deeper on NCT06772753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06772753.